Skip to content
Unrated Medical device recall · FDA · Published January 13, 2022

Nextrem: Cannulated Hammertoe Kit May Cause Surgical Delay or Revision

Nextremity Solutions recalls its Nextra CH Cannulated Hammertoe Mini Instrument Kit for potential surgical complications. The device may deform the implant locking mechanism during insertion, leading to delays or revision surgery.

🇺🇸 FDA recall #Z-0739-2022Medical deviceNextremity Solutions ›
Take action

Contact the company

Recalling firmNextremity Solutions1195 Polk Dr · Warsaw, IN 46582-8602
✎ GovInfoNow plain-language explainer

Nextremity Solutions is recalling its Nextra CH Cannulated Hammertoe Mini Instrument Kit because it can cause improper implant fitting during surgery. This may lead to surgical delays, removal of the implant, or needing a different surgical approach. Read more at govinfonow.com/recall/61270-nextrem-cannulated-hammertoe-kit-may-cause-surgical-delay-or-revision.

Source Summary by GovInfoNow · govinfonow.com/recall/61270-nextrem-cannulated-hammertoe-kit-may-cause-surgical-delay-or-revision · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0739-2022

Cite this page

“Nextrem: Cannulated Hammertoe Kit May Cause Surgical Delay or Revision.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61270-nextrem-cannulated-hammertoe-kit-may-cause-surgical-delay-or-revision. Based on FDA recall #Z-0739-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0739-2022%22&limit=1).

The FDA announced on Jan. 13, 2022, that Nextremity Solutions is recalling the Nextra CH Cannulated Hammertoe Mini Instrument Kit due to a hazard that may cause surgical delays and require implant removal. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Nextremity Solutions
  • Product: Nextra CH Cannulated Hammertoe Mini Instrument Kit
  • SKU: CH-MINI-KT
  • Lot Number: 1578401
  • UDI: 00817701026389

The hazard

According to the FDA, during insertion of the middle phalanx implant into bone, the driver may deform the implant locking mechanism. This can result in inadequate mating force between the middle and proximal phalanx implants, leading to surgical delay, in-situ removal of the implant, use of an alternative surgical approach, disassembly of the implants post-operatively, and revision.

Context

GovInfoNow's records show Nextremity Solutions has 6 other recalls on record since Oct. 9, 2019. Other recent recalls of similar products include Medartis APTUS Screws (April 24, 2026) and Merit Medical Custom Inflation Kit (Dec. 4, 2025).

How to tell if you have this one

Check for the SKU: CH-MINI-KT and Lot Number: 1578401 on the kit. The UDI is 00817701026389. This kit is used for small bone reconstruction in the toes.

  • Brand
    Nextremity Solutions
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    US Nationwide distribution in the states of AZ, IL, GA, LA, MD, NY, PA, TX, WA.
Recall numberProduct, codes & lotsQuantity
Z-0739-2022Nextra CH Cannulated Hammertoe Mini Instrument Kit-indicated for small bone reconstruction limited to inter-digital repair and fusion of the lesser toes SKU: CH-MINI-KT; Lot Number: 1578401 UDI: 0081770102638923 units
Z-0740-2022Nextra Cannulated Hammertoe Standard Instrument Kit-indicated for small bone reconstruction limited to inter-digital repair and fusion of the lesser toe SKU: CH-STD-KT; Lot Numbers: 1574701, 158961 UDI: 0081770102637224 units
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Nextremity Solutions directly for guidance on the recall.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 9 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: nationwideMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: nationwideMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: nationwideVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: nationwideALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: nationwideFL

FDA distribution: “US Nationwide distribution in the states of AZ, IL, GA, LA, MD, NY, PA, TX, WA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Arizona, Georgia, Illinois, Louisiana, Maryland, New York, Pennsylvania, Texas, Washington.

Recall timeline

FDA terminated this recall 2.4 years after the firm started it.

1. Firm started the recall: Jan 13, 202212. FDA classified it Class II: Mar 9, 202223. Published in FDA’s Enforcement Report: Mar 16, 202234. FDA terminated the recall: May 24, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0739-2022 (January 13, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0739-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA